Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
Healthcare | Drug Manufacturers - Major | USA
financial highlights | statements
IndexS&P 500 P/E39.09 EPS (ttm)3.13 Insider Own11.20% Shs Outstand1.04B Perf Week2.41%
Market Cap127.47B Forward P/E18.73 EPS next Y6.54 Insider Trans-2.44% Shs Float1.04B Perf Month4.86%
Income3.23B PEG3.45 EPS next Q1.31 Inst Own79.60% Short Float2.91% Perf Quarter8.98%
Sales24.56B P/S5.19 EPS this Y-37.00% Inst Trans-0.51% Short Ratio5.35 Perf Half Y18.53%
Book/sh12.82 P/B9.55 EPS next Y16.23% ROA-0.30% Target Price118.69 Perf Year59.00%
Cash/sh8.68 P/C14.11 EPS next 5Y11.35% ROE-1.10% 52W Range74.51 - 121.84 Perf YTD5.84%
Dividend2.58 P/FCF61.19 EPS past 5Y-15.00% ROI6.60% 52W High0.53% Beta0.31
Dividend %2.11% Quick Ratio1.50 Sales past 5Y0.20% Gross Margin73.80% 52W Low64.38% ATR2.47
Employees40655 Current Ratio1.90 Sales Q/Q7.10% Oper. Margin8.60% RSI (14)64.04 Volatility2.03% 2.03%
OptionableYes Debt/Eq0.97 EPS Q/Q112.90% Profit Margin-0.60% Rel Volume1.91 Prev Close120.75
ShortableYes LT Debt/Eq0.89 EarningsFeb 06 BMO Payout- Avg Volume5.66M Price122.48
Recom2.40 SMA203.58% SMA506.08% SMA20019.14% Volume10,786,009 Change1.43%
Jan-23-19Initiated UBS Buy $131
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Feb-15-19 04:21PM  Elanco Animal Health Incorporated -- Moody's announces completion of a periodic review of ratings of Elanco Animal Health Incorporated Moody's
02:56PM  Primecap Management Trims Eli Lilly Position GuruFocus.com
02:49PM  Hagens Berman: Judge Denies Insulin Makers Motion to Dismiss Class-Action Lawsuit Regarding Skyrocketing Insulin Prices Business Wire
11:43AM  Bayer gains full Vitrakvi rights from Eli Lilly's Loxo Reuters
11:33AM  Bayer gains full Vitrakvi rights from Eli Lilly's Loxo Reuters
10:28AM  Alkermes (ALKS) Q4 Earnings & Revenues Surpass Estimates Zacks
09:23AM  Lilly Completes Acquisition of Loxo Oncology PR Newswire
09:15AM  Are You Looking for a High-Growth Dividend Stock? Eli Lilly (LLY) Could Be a Great Choice Zacks
Feb-14-19 04:30PM  Lilly To Participate in Leerink Partners Global Healthcare Conference PR Newswire
01:49PM  Incyte (INCY) Q4 Earnings Miss Estimates, Revenues Beat Zacks
12:58PM  5 Drug/Biotech Stocks Set to Beat Estimates in Q4 Earnings Zacks
09:09AM  Thursdays Vital Data: Eli Lilly, Twitter and Freeport-McMoRan InvestorPlace
08:41AM  Teva (TEVA) Q4 Earnings Miss,'19 View Weak, Shares Down Zacks
06:30AM  Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride PR Newswire
Feb-13-19 03:07PM  Key Takeaways from Eli Lilly's (LLY) Q4 Earnings Report Zacks
10:28AM  J&J's (JNJ) Depression Treatment Gets FDA Committee's Nod Zacks
09:11AM  The Zacks Analyst Blog Highlights: Disney, Eli Lilly, U.S. Bancorp, Prudential and Alexion Zacks
08:36AM  5 Tiny Biotech Stocks With Superb Growth Potential Zacks
Feb-12-19 03:18PM  Top Stock Reports for Disney, Eli Lilly & U.S. Bancorp Zacks
Feb-11-19 09:31AM  Lilly to Begin Exchange Offer for Sale of Balance Elanco Stake Zacks
Feb-08-19 05:13PM  Teva (TEVA) to Report Q4 Earnings: What's in the Cards? Zacks
04:40PM  Mattel soars while Hasbro and Goodyear tumble Associated Press
04:33PM  Incyte Down as FDA Extends Review Period of Jakafi for GVHD Zacks
02:43PM  7 Fundamentally Sound Dividend Stocks to Buy InvestorPlace
01:29PM  Eli Lilly and Company -- Moody's: Lilly's animal health divestiture will reduce scale and diversity Moody's
01:00PM  Lilly to Participate in Guggenheim Healthcare Talks Idea Forum PR Newswire
11:20AM  Eli Lilly to Unload Its Remaining Stock in Elanco Animal Health Barrons.com
07:51AM  Pharma Stock Roundup: Q4 Earnings at MRK, LLY, CHMP Nod for Several Drugs Zacks
07:48AM  Stocks making the biggest moves premarket: Hasbro, Coty, Expedia, Verizon & more CNBC
07:45AM  New Research Coverage Highlights Eli Lilly, Newell Brands, Novanta, Carrols Restaurant Group, 8x8, and Quanta Services Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
06:57AM  Eli Lilly to divest remaining stake in Elanco via an exchange offer MarketWatch
06:45AM  Lilly Will Initiate Divestiture of its Remaining Interest in Elanco Animal Health PR Newswire
Feb-07-19 06:54PM  Edited Transcript of LLY earnings conference call or presentation 6-Feb-19 2:00pm GMT Thomson Reuters StreetEvents
09:30AM  Stock Market News For Feb 7, 2019 Zacks
08:32AM  Sanofi (SNY) Q4 Earnings Top, Genzyme Unit Drives Sales Growth Zacks
07:31AM  5 Reasons Eli Lilly Investors Look Can Look Past Lartruvo's Failure Motley Fool
Feb-06-19 04:36PM  Stocks End Lower as Wall Street Gets No Boost From State of the Union TheStreet.com
04:33PM  Eli Lilly Misses Q4 Earnings, Cuts 2019 Outlook After Loxo Oncology Deal TheStreet.com
04:12PM  This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag Investor's Business Daily
03:04PM  Eli Lilly & Co (LLY) Q4 2019 Earnings Conference Call Transcript Motley Fool
01:49PM  This Top Pharma Stock Undercut A Buy Point On Its Earnings Lag Investor's Business Daily
01:48PM  Eli Lilly Stock Falls Because 2019 Isnt 2018 Barrons.com
11:22AM  Eli Lilly backs U.S. proposal on drug rebates to lower costs Reuters
11:22AM  Eli Lilly cuts 2019 forecast on trial failure, Loxo deal Reuters
09:37AM  Lilly (LLY) Lags Q4 Earnings, Lowers 2019 View, Stock Down Zacks
08:45AM  Eli Lilly (LLY) Lags Q4 Earnings, Tops Sales, Cuts 2019 View Zacks
08:23AM  The Daily Biotech Pulse: Paratek Launches Antibiotic In US, Eli Lilly Earnings, Catabasis Offering Benzinga
08:09AM  Small-Caps Are Making Big Moves in This Technically Extended Market TheStreet.com
08:01AM  Stocks making the biggest moves premarket: Eli Lilly, Humana, Disney, Spotify & more CNBC
07:59AM  [$$] Eli Lilly cuts 2019 outlook after trial failure and Loxo deal Financial Times
07:54AM  Lilly lowers 2019 forecast due to drug failure, pending deal Associated Press
07:45AM  Eli Lilly cuts 2019 forecast on trial failure, Loxo deal Reuters
07:25AM  [$$] Eli Lilly Swings to Profit in Latest Quarter The Wall Street Journal
06:41AM  Eli Lilly's stock falls after profit miss, lowered outoook MarketWatch
06:25AM  Lilly Reports Strong Fourth-Quarter and Full-Year 2018 Financial Results, Lowers 2019 EPS Guidance to Reflect the Pending Acquisition of Loxo Oncology PR Newswire
01:43AM  Stocks - U.S. Futures Inch Down Ahead of GM Earnings Investing.com
01:33AM  Eli Lilly Earnings miss, Revenue beats In Q4 Investing.com
12:28AM  Top 5 Things to Know in The Market on Wednesday Investing.com
Feb-05-19 09:53AM  Sanofi's Myeloma Candidate Meets Goal in Phase III Study Zacks
09:19AM  Merck's Keytruda Clinches CHMP Nod for Difficult Lung Cancer Zacks
09:02AM  Roche Submits sBLA to FDA for Label Expansion of Kadcyla Zacks
08:15AM  Allergan Stock Falls as FDA OK's Botox Rival for Frown Lines Zacks
08:07AM  Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies Zacks
07:47AM  The Daily Biotech Pulse: Gilead Earnings, Codexis Sings Pact With Merck, Eli Lilly Reports Positive Trial Results Benzinga
Feb-04-19 12:57PM  Eli Lilly Is Trading Strong Ahead of Earnings on Wednesday TheStreet.com
12:12PM  5 of the Best Biotech Stocks to Buy Now InvestorPlace
09:50AM  Teva Gains Positive CHMP Opinion for Migraine Drug Ajovy Zacks
06:45AM  Lilly Announces Top-Line Phase 3 Results for Baricitinib in Patients with Moderate to Severe Atopic Dermatitis PR Newswire
Feb-03-19 11:34AM  Here's Why Array BioPharma Jumped 31% in January Motley Fool
12:59AM  Economic Calendar - Top 5 Things to Watch This Week Investing.com
Feb-01-19 06:11PM  Cramer's game plan: Be ready to 'buy the next dip' in this 'ideal backdrop for stocks' CNBC
03:59PM  Exclusive: Top U.S. insurer to cover Amgen, Eli Lilly migraine drugs, exclude Teva Reuters
12:13PM  Novo Nordisk (NVO) Q4 Earnings Miss Estimates, Revenues Beat Zacks
10:15AM  Pharma Catches Another Case Of M&A Fever Benzinga
09:15AM  Lilly (LLY) Hits 52-Week High, Can the Run Continue? Zacks
09:10AM  The Daily Biotech Pulse: Merck Earnings, Positive Relaunch Of Titan's Opioid Disorder Treatment Implant Benzinga
08:15AM  Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY Zacks
06:45AM  Lilly and Loxo Oncology Announce Expiration of HSR Act Waiting Period in Connection with Proposed Transaction PR Newswire
Jan-31-19 07:23PM  J&J's Erleada Meets Both Primary Endpoints in Late-Stage Study Zacks
04:21PM  This Pharma Stock Broke Out On Its Merck-Partnered Cancer Regimen Investor's Business Daily
09:52AM  Eli Lilly (LLY) Q4 Earnings Coming Up: What's in the Cards? Zacks
06:45AM  FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the First-Line Treatment of Metastatic Nonsquamous Non-Small Cell Lung Cancer PR Newswire
Jan-30-19 03:15PM  Lilly Revises Date for Fourth-Quarter 2018 Financial Results Announcement PR Newswire
01:26PM  U.S. lawmakers request info from insulin makers on rising prices Reuters
10:57AM  House Democratic leaders probe 3 major drugmakers on insulin prices CNBC
08:52AM  Lilly/Pfizer's Osteoarthritis Pain Drug Succeeds in 2nd Study Zacks
Jan-29-19 09:08AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
06:30AM  Pfizer and Lilly Announce Top-Line Results From Second Phase 3 Study of Tanezumab in Osteoarthritis Pain Business Wire
Jan-28-19 05:55PM  Dr. Reddy's (RDY) to Report Q3 Earnings: What's in Store? Zacks
12:37PM  Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results Zacks
10:07AM  The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck Zacks
Jan-25-19 03:43PM  Exclusive: CVS to cover migraine drugs from Teva, Lilly; excludes Amgen Reuters
10:23AM  Pharma Stock Roundup: JNJ & BMY's Q4 Earnings, Study Failures at LLY & ABBV Zacks
09:44AM  Merck KGaA Gives Vertex Rights to Two Gene-Editing Compounds Zacks
Jan-24-19 02:30PM  Moderna's Hot New mRNA Technology Has Competition Motley Fool
01:00PM  What's Behind the Biotech ETF Rally to Start 2019? Zacks
11:59AM  Skyrocketing health care costs key topic at Davos Yahoo Finance Video
11:58AM  Bristol-Myers (BMY) Beats Q4 Earnings, Withdraws Opdivo sBLA Zacks
10:50AM  The Zacks Analyst Blog Highlights: Archer Daniels Midland, Molina Healthcare, Eli Lilly, Spark Energy and Lamb Weston Zacks
10:40AM  Sanofi's (SNY) Influenza Vaccine Gets FDA Approval for Kids Zacks
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; and Dicerna Pharmaceuticals, Inc., as well as has strategic collaboration with Sigilon Therapeutics and AC Immune SA. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.009,722050,946Feb 05 07:09 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0012,2220131,708Feb 05 07:04 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0012,7780102,548Feb 05 06:59 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.008,8890109,100Feb 05 06:55 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0012,2220136,756Feb 05 06:49 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.003,333020,901Feb 05 06:43 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.003,221054,175Feb 06 08:10 PM
LILLY ENDOWMENT INC10% OwnerJan 17Sale118.33136,57716,161,281117,825,304Jan 18 01:14 PM
LILLY ENDOWMENT INC10% OwnerJan 16Sale117.871,657195,315117,961,881Jan 17 01:15 PM
LILLY ENDOWMENT INC10% OwnerJan 15Sale117.7451,7666,095,136117,963,538Jan 16 02:36 PM
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
open in yahoo | open in reuters | open in google